Acquired FXI deficiency in a systemic lupus erythematosus patient: Evolution and coagulation phenotypic changed to lupus anticoagulant during immunosuppressive therapy

Int J Lab Hematol. 2022 Dec;44(6):e269-e274. doi: 10.1111/ijlh.13937. Epub 2022 Jul 26.

Affiliations

¹ Central Laboratory, Biochemistry, Instituto Universitario del Hospital Italiano de Buenos Aires, Buenos Aires, CABA, Argentina.
² Hematology, Hospital Italiano de Buenos Aires, Buenos Aires, CABA, Argentina.
³ Rheumatology, Hospital Italiano de Buenos Aires, Buenos Aires, CABA, Argentina.
⁴ Central Laboratory, Instituto Universitario del Hospital Italiano de Buenos Aires, Buenos Aires, CABA, Argentina.

PMID: 35883223
DOI: 10.1111/ijlh.13937

No abstract available

Publication types

Letter

MeSH terms

Antiphospholipid Syndrome*
Blood Coagulation
Blood Coagulation Factors
Humans
Immunosuppression Therapy
Lupus Coagulation Inhibitor
Lupus Erythematosus, Systemic* / complications
Lupus Erythematosus, Systemic* / drug therapy

Substances

Lupus Coagulation Inhibitor
Blood Coagulation Factors